|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.800 USD | -3.55% |
|
-2.56% | -5.00% |
| 01-02 | Evolent reports inducement award under NYSE listing rule 303A.08 | RE |
| 12-18 | Syra Health Corp. Appoints Gregory R. Alexander as Chief Executive Officer, Effective January 5, 2026 | CI |
| Capitalization | 424M 363M 337M 316M 586M 38.85B 627M 3.86B 1.53B 18.36B 1.59B 1.56B 67.06B | P/E ratio 2025 * |
-2.63x | P/E ratio 2026 * | -6.17x |
|---|---|---|---|---|---|
| Enterprise value | 1.22B 1.04B 968M 908M 1.68B 112B 1.8B 11.11B 4.39B 52.78B 4.57B 4.48B 193B | EV / Sales 2025 * |
0.65x | EV / Sales 2026 * | 0.48x |
| Free-Float |
94.8% | Yield 2025 * |
5.84% | Yield 2026 * | 2.78% |
Last Transcript: Evolent Health, Inc.
| 1 day | -3.55% | ||
| 1 week | -2.56% | ||
| Current month | -5.00% | ||
| 1 month | -4.76% | ||
| 3 months | -53.55% | ||
| 6 months | -61.07% | ||
| Current year | -5.00% |
| 1 week | 3.68 |  | 4 |
| 1 month | 3.68 | | 4.26 |
| Current year | 3.68 | | 4.26 |
| 1 year | 3.5 | | 12.06 |
| 3 years | 3.5 | | 36.7 |
| 5 years | 3.5 | | 39.78 |
| 10 years | 3.5 | | 39.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Blackley
CEO | Chief Executive Officer | 47 | 30/09/2020 |
Mario Ramos
DFI | Director of Finance/CFO | 55 | 31/12/2025 |
Dan McCarthy
PSD | President | - | 14/09/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Blackley
BRD | Director/Board Member | 47 | 17/04/2018 |
Peter Grua
BRD | Director/Board Member | 71 | 31/01/2020 |
Craig Barbarosh
BRD | Director/Board Member | 58 | 20/12/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.55% | -2.56% | -62.64% | -87.67% | 424M | |
| +1.60% | +0.40% | -1.48% | +35.27% | 36.12B | |
| -0.52% | -14.02% | -33.82% | +180.64% | 12.6B | |
| +1.08% | -3.35% | -10.22% | +37.41% | 4.71B | |
| +3.33% | +1.64% | - | - | 4.17B | |
| -1.87% | -4.09% | - | - | 2.86B | |
| +0.47% | +8.22% | - | - | 2.81B | |
| +2.89% | -0.47% | +17.64% | -9.86% | 2.27B | |
| -1.71% | -13.86% | +9.59% | - | 1.45B | |
| Average | +0.19% | -3.71% | -13.49% | +31.16% | 7.49B | |
| Weighted average by Cap. | +1.02% | -3.34% | -8.70% | +65.34% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.88B 1.6B 1.49B 1.4B 2.59B 172B 2.77B 17.09B 6.76B 81.21B 7.03B 6.89B 297B | 2.38B 2.04B 1.89B 1.77B 3.29B 218B 3.53B 21.72B 8.59B 103B 8.94B 8.76B 377B |
| Net income | -166M -142M -132M -123M -229M -15.19B -245M -1.51B -598M -7.18B -622M -609M -26.23B | -72.86M -62.29M -57.83M -54.23M -101M -6.67B -108M -664M -263M -3.15B -273M -268M -11.52B |
| Net Debt | 795M 680M 631M 592M 1.1B 72.84B 1.18B 7.24B 2.87B 34.42B 2.98B 2.92B 126B | 719M 615M 570M 535M 993M 65.83B 1.06B 6.55B 2.59B 31.11B 2.7B 2.64B 114B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/01/26 | 3.800 $ | -3.55% | 2,551,841 |
| 20/01/26 | 3.940 $ | +4.51% | 4,295,824 |
| 16/01/26 | 3.770 $ | -4.31% | 7,018,401 |
| 15/01/26 | 3.940 $ | +1.03% | 1,899,701 |
| 14/01/26 | 3.900 $ | -2.74% | 2,300,656 |
Delayed Quote Nyse, January 21, 2026 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EVH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition